ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2497

Factors Influencing Time to Diagnosis in U.S. Patients with Systemic Lupus Erythematosus

Joy Buie, Lupus Foundation of America, York, SC

Meeting: ACR Convergence 2023

Keywords: Access to care, Diagnostic criteria, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: Abstracts: Interprofessional OA & Lupus

Session Type: Abstract Session

Session Time: 2:00PM-3:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a complex autoimmune disease defined by its heterogeneity and cycles of flares and remissions. Owing to non-specific or incomplete sequelae, diagnosing lupus represents a considerable clinical challenge. Despite increased awareness among physicians and patients, considerable diagnostic delays in SLE persist. The objective of this study was to identify factors contributing to delays in SLE diagnosis.

Methods: We performed cross-sectional analysis of 925 US patients with SLE registered in the Lupus Foundation of America Research Accelerated by You (RAY®) registry from October 2020 to May 2023. The Accelerated Failure Time model was used to ascertain factors influencing time to diagnosis. Demographics variables including age, sex, race as well as onset of first symptoms and time of diagnosis were evaluated. The potential effect of income, educational attainment and US region were also determined.

Results: All participants included in the analysis were ultimately diagnosed with lupus. The average duration from symptom onset and diagnosis is 6.29±0.277 SE years. Using a multivariable log-logistic AFT model, we observed that age (β=.019, p< .001), residence in the southern region (β=0.227, p=.024) and identification as American Indian/Alaska Native (β=0.651,p=.008) were associated with prolonged time to SLE diagnosis. Conversely, Asian (β=-0.545, p=.006) and Black/African American race (β=-.366, p=.002) showed association with a shorter time to diagnosis. Evaluation of income indicated a potential association with a shorter time to diagnosis (β=-0.049, p=0.063); however, it was not statistically significant.

Conclusion: Diagnostic delays remain a considerable issue for individuals eventually diagnosed with lupus. Factors such as race, regional location, and age may contribute to time to diagnosis. Additional research is needed to explore the relationship between these variables and the timing of SLE diagnosis.


Disclosures: J. Buie: None.

To cite this abstract in AMA style:

Buie J. Factors Influencing Time to Diagnosis in U.S. Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/factors-influencing-time-to-diagnosis-in-u-s-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-influencing-time-to-diagnosis-in-u-s-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology